| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.45 | 0.1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |